3-Acetylpyridine: a tool to inhibit the tremor and the increase of cGMP content in cerebellar cortex elicited by harmaline.
D000470:Alkaloids / Q000037:antagonists & inhibitors*; D000818:Animals; D001923:Brain Chemistry; D002525:Cerebellar Cortex / Q000187:drug effects*; D006152:Cyclic GMP / Q000378:metabolism*; D005971:Glutamates / Q000494:pharmacology; D006246:Harmaline / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D008297:Male; D010095:Oxotremorine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D014202:Tremor / Q000139:chemically induced* / Q000188:drug therapy
D000470:Alkaloids; D005971:Glutamates; D011725:Pyridines; C010835:3-acetylpyridine; D010095:Oxotremorine; D006246:Harmaline; D006152:Cyclic GMP